Myles Minter
Stock Analyst at William Blair
(1.44)
# 3,573
Out of 5,124 analysts
23
Total ratings
52.94%
Success rate
-1.68%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Myles Minter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KRRO Korro Bio | Downgrades: Market Perform | n/a | $8.01 | - | 2 | Nov 13, 2025 | |
| BHVN Biohaven | Downgrades: Market Perform | n/a | $11.29 | - | 1 | Nov 5, 2025 | |
| ALEC Alector | Downgrades: Market Perform | n/a | $1.56 | - | 2 | Oct 22, 2025 | |
| DNTH Dianthus Therapeutics | Initiates: Outperform | n/a | $41.21 | - | 1 | Jul 2, 2025 | |
| IMUX Immunic | Initiates: Outperform | n/a | $0.53 | - | 1 | Mar 25, 2025 | |
| CAMP Camp4 Therapeutics | Initiates: Outperform | n/a | $6.13 | - | 1 | Nov 5, 2024 | |
| ARGX argenx SE | Upgrades: Outperform | n/a | $840.95 | - | 2 | Nov 1, 2024 | |
| NMRA Neumora Therapeutics | Initiates: Outperform | n/a | $1.79 | - | 1 | Oct 10, 2023 | |
| ARCT Arcturus Therapeutics Holdings | Initiates: Outperform | $71 | $6.13 | +1,058.24% | 1 | Jul 24, 2023 | |
| MRNA Moderna | Initiates: Market Perform | n/a | $29.49 | - | 1 | Jul 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $453.36 | - | 1 | May 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $294.74 | - | 2 | Mar 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $3.81 | - | 3 | Sep 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $397.65 | - | 1 | Jun 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $79.11 | - | 2 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $116 | $141.83 | -18.21% | 1 | Feb 24, 2020 |
Korro Bio
Nov 13, 2025
Downgrades: Market Perform
Price Target: n/a
Current: $8.01
Upside: -
Biohaven
Nov 5, 2025
Downgrades: Market Perform
Price Target: n/a
Current: $11.29
Upside: -
Alector
Oct 22, 2025
Downgrades: Market Perform
Price Target: n/a
Current: $1.56
Upside: -
Dianthus Therapeutics
Jul 2, 2025
Initiates: Outperform
Price Target: n/a
Current: $41.21
Upside: -
Immunic
Mar 25, 2025
Initiates: Outperform
Price Target: n/a
Current: $0.53
Upside: -
Camp4 Therapeutics
Nov 5, 2024
Initiates: Outperform
Price Target: n/a
Current: $6.13
Upside: -
argenx SE
Nov 1, 2024
Upgrades: Outperform
Price Target: n/a
Current: $840.95
Upside: -
Neumora Therapeutics
Oct 10, 2023
Initiates: Outperform
Price Target: n/a
Current: $1.79
Upside: -
Arcturus Therapeutics Holdings
Jul 24, 2023
Initiates: Outperform
Price Target: $71
Current: $6.13
Upside: +1,058.24%
Moderna
Jul 24, 2023
Initiates: Market Perform
Price Target: n/a
Current: $29.49
Upside: -
May 30, 2023
Initiates: Outperform
Price Target: n/a
Current: $453.36
Upside: -
Mar 6, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $294.74
Upside: -
Sep 19, 2022
Upgrades: Outperform
Price Target: n/a
Current: $3.81
Upside: -
Jun 7, 2022
Initiates: Outperform
Price Target: n/a
Current: $397.65
Upside: -
Dec 14, 2021
Upgrades: Outperform
Price Target: n/a
Current: $79.11
Upside: -
Feb 24, 2020
Initiates: Outperform
Price Target: $116
Current: $141.83
Upside: -18.21%